Opiant Pharmaceuticals Inc. (OPNT): Boton: about time. nice move. I love wh...

Followed By	43
Posts	8897
Boards Moderated	0
Alias Born	06/23/2005

catty

Friday, August 09, 2019 2:32:43 PM

Re: BostonSportsNut post# 1464

Boton: about time. nice move. I love what they're doing, that's mainly why I'm in the stock. It's such a major problem today - fortunately I've never been on drugs.

Recent OPNT News

Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 06/17/2022 08:54:48 PM
Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 06/17/2022 08:52:54 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/15/2022 08:32:07 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/14/2022 09:01:15 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/14/2022 08:56:26 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/14/2022 08:54:38 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/14/2022 08:49:52 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 06/14/2022 08:17:44 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/13/2022 08:56:16 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/13/2022 08:06:13 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/08/2022 08:40:06 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 06/08/2022 08:10:24 PM
Opiant Pharmaceuticals and Aptar Pharma Expand Long-Term Collaboration for the Manufacture of Unidose Nasal Spray for OPNT003, Nasal Nalmefene • GlobeNewswire Inc. • 06/08/2022 08:05:00 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/06/2022 08:58:33 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/06/2022 08:08:21 PM
Opiant Pharmaceuticals Initiates Rolling Submission of New Drug Application to U.S. Food and Drug Administration for OPNT003, Nasal Nalmefene, for the Treatment of Opioid Overdose • GlobeNewswire Inc. • 06/01/2022 08:05:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 05/23/2022 08:12:20 PM
Opiant Pharmaceuticals to Hold Virtual 2022 Annual Shareholder Meeting on Tuesday, June 14, 2022 at 9:00am PDT • GlobeNewswire Inc. • 05/20/2022 08:05:00 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 05/17/2022 08:05:15 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 05/16/2022 08:13:25 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 05/16/2022 08:11:32 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 05/10/2022 08:10:23 PM
Opiant Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/10/2022 08:01:00 PM
Opiant Pharmaceuticals to Report First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 10, 2022 • GlobeNewswire Inc. • 05/03/2022 12:00:00 PM
Opiant Pharmaceuticals Issues Statement in Response to Fake Press Release • PR Newswire (US) • 04/29/2022 04:49:00 PM

More OPNT News

InvestorsHub NewsWire

IGEN Networks Corporation wins award to provide Medallion GPS to New York State Counties • IGEN • Jun 24, 2022 6:00 AM

BOX Pure Air Supplies Highland Park Independent School District (TX) AIRBOX ™ Air Purification Units Improving Air Quality in Schools • SING • Jun 23, 2022 1:05 PM

Gaensel Energy Group, Inc. (GEGR) Presents Its Partners and Activities of Its CONSORZIO GREEN SOLUTION & GNL • GEGR • Jun 23, 2022 11:40 AM

Resgreen Group Announces Major Milestone with LilBuddy ™ Pilot Testing • RGGI • Jun 23, 2022 7:07 AM

Demand Brands engages BF Borgers CPA PC as auditor • DMAN • Jun 22, 2022 9:11 AM

Global Fiber Technologies, Inc., Closes its First Round of Inventory Financing. • GFTX • Jun 22, 2022 9:00 AM

Maison Luxe Appoints Aether Diamonds CEO Ryan Shearman to Its Board of Directors • MASN • Jun 22, 2022 8:54 AM

Pasithea Therapeutics Acquires Alpha-5 Integrin, LLC • KTTA • Jun 22, 2022 8:07 AM

Amesite Launches V5 Platform, Enabling Every Business, University and Museum to Deliver or Sell AI-Powered, Branded eLearning • AMST • Jun 22, 2022 7:34 AM

Dalrada Financial Corporation Appoints Brian McGoff as President and Chief Operating Officer • DFCO • Jun 21, 2022 9:30 AM

Global Arena Holding Initiates 1 for 12 Reverse in Support of Potential Capital and Growth Endeavors • GAHC • Jun 21, 2022 7:21 AM

Hillcrest Investor Technology Poised For Central Role In The Reimagined Energy Future • HLRTF • Jun 20, 2022 6:04 AM

Co Brand Partners Investing in Social Revolution Jun 17, 2022 4:00 AM

Resgreen Group Announces Release of Significant Update to BotWay ™ Fleet and Management System • RGGI • Jun 16, 2022 6:00 AM

GoDaddy Founder, Bob Parsons Details Journey of Healing Through Psychedelics in Exclusive Interview With PSYC • PSYC • Jun 15, 2022 8:30 AM

Start posting your company's news
Only $200 per official company press release!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Quotes:

IHub:

More OPNT News

Detailed Quote